Scrip M&A Podcast: Assessing The Biopharma Deals Environment At Midyear

 
• By Joseph Haas, Kevin Grogan, and Mandy Jackson

With the first half of 2024 in the books, Scrip’s Joseph Haas, Mandy Jackson and Kevin Grogan discuss the dealmaking environment at the year’s midpoint and expectations for the second half.

Midyear M&A podcast
Scrip editors look ahead to biopharma dealmaking in the second half of 2024 • Source: Shutterstock

More from Strategy

More from Business